Back
Chicago Atlantic Real Estate Finance, Inc. Vs. Zenas BioPharma, Inc. Industry Stock Comparison
Sell
34
REFI
Chicago Atlantic Real Estate Finance, Inc.
Last Price:
$12.83
Seasonality Move:
-3.62%
Buy
60
ZBIO
Zenas BioPharma, Inc.
Last Price:
$42.76
Seasonality Move:
0.59%
Sell
34
Chicago Atlantic Real Estate Finance, Inc. (REFI)
is a Sell
Is Chicago Atlantic Real Estate Finance, Inc. a Buy, Sell or Hold?
-
The current Chicago Atlantic Real Estate Finance, Inc. [REFI] share price is $12.92. The Score for REFI is 34, which is 32% below its historic median score of 50, and infers higher risk than normal.
-
REFI is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Buy
60
Zenas BioPharma, Inc. (ZBIO)
is a Buy
Is Zenas BioPharma, Inc. a Buy, Sell or Hold?
-
The current Zenas BioPharma, Inc. [ZBIO] share price is $42.33. The Score for ZBIO is 60, which is 20% above its historic median score of 50, and infers lower risk than normal.
-
ZBIO is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
REFI Stock Price Chart
What is Chicago Atlantic Real Estate Finance, Inc.'s stock price today?
-
The Chicago Atlantic Real Estate Finance, Inc. share price today is $12.92Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and REFI is experiencing selling pressure, which indicates risk of future bearish movement.
ZBIO Stock Price Chart
What is Zenas BioPharma, Inc.'s stock price today?
-
The Zenas BioPharma, Inc. share price today is $42.33Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and ZBIO is experiencing buying pressure, which is a positive indicator for future bullish movement.
REFI Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 2.89 | Buy |
| Relative Strength Index (14 RSI): | 51.18 | Buy |
| Chaikin Money Flow: | -99225 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (12.4 - 13.06) | Buy |
| Bollinger Bands (100): | (12.56 - 13.78) | Sell |
ZBIO Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 8.47 | Buy |
| Relative Strength Index (14 RSI): | 61.08 | Buy |
| Chaikin Money Flow: | 587345 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (35.32 - 39.82) | Buy |
| Bollinger Bands (100): | (17.72 - 34.64) | Buy |
REFI Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 13.06 | Sell |
| 20-day SMA: | 12.85 | Buy |
| 50-day SMA: | 12.81 | Buy |
| 200-day SMA: | 13.78 | Sell |
| 8-day EMA: | 8.25 | Buy |
| 20-day EMA: | 4.29 | Buy |
| 50-day EMA: | 1.93 | Buy |
| 200-day EMA: | 0.51 | Buy |
ZBIO Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 37.46 | Buy |
| 20-day SMA: | 37.97 | Buy |
| 50-day SMA: | 33.51 | Buy |
| 200-day SMA: | 18.21 | Buy |
| 8-day EMA: | 24.11 | Buy |
| 20-day EMA: | 12.41 | Buy |
| 50-day EMA: | 5.54 | Buy |
| 200-day EMA: | 1.47 | Buy |
Chicago Atlantic Real Estate Finance, Inc. Earnings Growth & REFI Earnings Dates
-
Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.30 per share, and an increase next year of $0.29 per share.
Zenas BioPharma, Inc. Earnings Growth & ZBIO Earnings Dates
-
Analysts estimate an earnings increase this quarter of $0.21 per share, a decrease next quarter of $0.00 per share, an increase this year of $2.65 per share, and an increase next year of $0.59 per share.
Chicago Atlantic Real Estate Finance, Inc. Technical Analysis
| Dec 9 | Dec 10 | Dec 11 | Dec 12 | Dec 15 | Dec 16 | Dec 17 | Dec 18 | Dec 19 | Dec 22 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec | ||||||||||
| 09 | 10 | 11 | 12 | 15 | 16 | 17 | 18 | 19 | 22 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Zenas BioPharma, Inc. Technical Analysis
| Dec 9 | Dec 10 | Dec 11 | Dec 12 | Dec 15 | Dec 16 | Dec 17 | Dec 18 | Dec 19 | Dec 22 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec | ||||||||||
| 09 | 10 | 11 | 12 | 15 | 16 | 17 | 18 | 19 | 22 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||